Results 261 to 270 of about 75,386 (292)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's Disease

Journal of Pharmacology and Experimental Therapeutics, 2012
E. Le Poul, C. Boléa, Françoise Girard, S. Poli, D. Charvin, B. Campo, Julien Bortoli, Abdhelak Bessif, Bin Luo, A. Koser, Lisa Hodge, K. Smith, A. Dilella, N. Liverton, Fred J Hess, S. Browne, I. Reynolds   +16 more
semanticscholar   +1 more source

Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism

The FASEB Journal, 2009
C. Beurrier, S. Lopez, Delphine Révy, C. Selvam, C. Goudet, M. Lhérondel, P. Gubellini, L. Kerkerian-Legoff, F. Acher, J. Pin, M. Amalric   +10 more
semanticscholar   +1 more source

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature

Expert Opinion on Therapeutic Patents, 2012
C. Lindsley, C. Hopkins
semanticscholar   +1 more source

Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia

Neuropharmacology, 2013
K. Bennouar, M. Uberti, C. Melon, M. Bacolod, H. Jimenez, M. Cajina, L. Goff, D. Doller, P. Gubellini   +8 more
semanticscholar   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders

Expert Opinion on Drug Discovery, 2012
Sylvain Celanire, B. Campo
semanticscholar   +1 more source